CURETIS

Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
CURETIS
Industry:
Biotechnology Genetics Health Diagnostics Medical
Founded:
2007-01-01
Address:
Holzgerlingen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.curetis.com
Total Employee:
11+
Status:
Active
Total Funding:
75.1 M EUR
Technology used in webpage:
Euro Ninja Forms 3 To 9 CcTLD Redirects
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Board_member
Current Employees Featured
Johannes Bacher Co-Founder and COO @ Curetis
Co-Founder and COO
Andreas Boos Co-Founder and CTO @ Curetis
Co-Founder and CTO
2008-01-01
Achim Plum CBO @ Curetis
CBO
2017-12-01
Oliver Schacht Managing Director @ Curetis
Managing Director
2011-04-01
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Curetis
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Debt - Curetis
Aeris Capital
Aeris Capital investment in Series B - Curetis
BioMedPartners
BioMedPartners investment in Series B - Curetis
CD-Venture
CD-Venture investment in Series B - Curetis
HBM Partners
HBM Partners investment in Series B - Curetis
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Curetis
Roche Venture Fund
Roche Venture Fund investment in Series B - Curetis
Life Sciences Partners
Life Sciences Partners investment in Series B - Curetis
Roche Venture Fund
Roche Venture Fund investment in Series A - Curetis
Newest Events participated


Official Site Inspections
http://www.curetis.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "Curetis"
Curetis - Crunchbase Company Profile & Funding
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. …See details»
Curetis 2025 Company Profile: Valuation, Funding
Curetis General Information Description. Manufacturer of molecular diagnostic products intended to improve patient outcomes. The company offers a rapid …See details»
Curetis GmbH Information - RocketReach
Curetis has entered into several international distribution agreements covering many countries across Europe, the Middle East and Asia. In 2017, Curetis established Ares Genetics GmbH, a …See details»
Curetis Company Profile - Office Locations, Competitors ... - Craft
May 4, 2020 Curetis has 2 employees at their 1 location and €1.42 m in annual revenue in FY 2018. See insights on Curetis including office locations, competitors, revenue, financials, …See details»
Curetis CEO and Key Executive Team | Craft.co
Curetis's key executives include Oliver Schacht and 11 others. Oliver Schacht. CEO. Johannes Bacher. COO. Andreas Boos. CTO. Chris Emery. President & CEO, Curetis USA. Faranak …See details»
Curetis AG - Holzgerlingen, Germany
Aug 18, 2017 Curetis has entered into several international distribution agreements covering many countries across Europe, the Middle East and Asia. In 2017, Curetis established Ares …See details»
Curetis GmbH Overview | SignalHire Company Profile
Curetis GmbH is a private company that has been in the industry for 16 years. The company currently specializes in the Medical Devices, Biotechnology areas. ... Organization Website: …See details»
Curetis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
curetis (Curetis GmbH) - Startbase
Die neusten Erwähnungen von curetis in Podcasts & Videos: Offene Jobs bei curetis: Weitere Startups in der Nähe von curetis. NEWDRIVE Analytics. Startup 2022 Holzgerlingen. …See details»
Curetis - Contacts, Employees, Board Members, Advisors & Alumni
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases. New. Resources. ... Log In. Experience the new …See details»
Curetis - Overview, News & Similar companies | ZoomInfo.com
Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, …See details»
Curetis - F6S
Similar companies GeneSys Bio s.r.l. Saving Lives by making infection detection faster and more accessible. Clemedi Clemedi: Give the right antibiotics! Hyris Biotech company active in the …See details»
Curetis - EQT Group
Curetis. Dental care with ambition. Curaeos is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. Key Facts. Sector. Life …See details»
Curetis - Raised $127M Funding from 13 investors - Tracxn
Feb 27, 2025 List of Curetis's institutional investors. BMBF, located in Berlin (Germany), made their first investment in Curetis on Sep 30, 2020 in its Grant (prize money) round.; European …See details»
Curetis | Science Company | Labroots
Oct 29, 2024 Curetis offers a rapid molecular diagnostic solution with broad coverage of pathogens and resistance markers.See details»
This Diagnostic Tool beats the Standard for Respiratory Infection …
Oct 25, 2016 Curetis is a German biotech that commercializes diagnostic technologies for infectious diseases. ... The World Health Organization (WHO) expects infectious diseases to …See details»
OpGen, Curetis to Merge, Creating $24M MDx Developer Focused …
Sep 6, 2019 “We are convinced that the combination of OpGen and Curetis will help maximize value for our stockholders and will result in an organization with a robust pipeline of molecular …See details»
Curetis Spins Out Antibiotic Resistance Test Company Ares Genetics
Apr 6, 2017 Molecular diagnostics firm Curetis was founded in 2007 to develop rapid diagnostics for severe infectious diseases. The Germany-based company’s flagship Unyvero platform and …See details»
OpGen Subsidiaries Curetis, Ares Genetics File for Bankruptcy
Nov 7, 2023 Curetis filed a petition for bankruptcy protection with the district court of Stuttgart, Germany, while Ares Genetics filed with the commercial court in Vienna. The insolvency …See details»
Otis CEO Judy Marks Inside the Strategy Room | McKinsey
Mar 11, 2025 Otis has been shaping urban mobility for over 170 years. CEO and Chair Judy Marks discusses how she steers the company through geopolitical shifts, technological …See details»